News

Belmont Plastic Surgery has expanded its portfolio of advanced abdominoplasty procedures at its Chevy Chase location, introducing a broader range of surgical options designed to deliver more personalized body contouring…

Reality television personality Hannah Elizabeth has shared an update on her recovery after undergoing a facelift and neck liposuction, giving fans a glimpse of the results just days after the…

Brazilian authorities have arrested fitness influencer Larissa da Silva Caetano Anunciação, known online as Larissa Caetano, and her husband on suspicion of illegally selling prescription weight-loss medications through social media…

An estimated one in 10 Americans has used a GLP-1 medication for weight loss, fueling a rapid rise in demand for the drugs even as questions persist about their safety,…

Novo Nordisk is doubling down on the obesity market, signing a deal worth up to $2.1 billion with Boston-based biotech Vivtex to develop next-generation oral weight-loss therapies, just days after…

Novo Nordisk and its Chinese partner, United Laboratories, have reported promising mid-stage trial results for their experimental obesity therapy UBT251, with patients losing up to 19.7% of their body weight…

A 74-year-old woman has captured widespread attention on social media after appearing in a TikTok video that showcased her notably toned stomach, surprising viewers and sparking conversations about aging, fitness,…

A new meta-analysis suggests that metabolic and bariatric surgery (MBS) may offer stronger long-term cardiovascular protection than widely used glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in people living with type…

Recent clinical trials and policy developments are reshaping the fields of obesity treatment, diabetes care, and endocrine research, with several investigational therapies demonstrating notable outcomes while regulatory and legal shifts…

Country music star Luke Combs is speaking candidly about his health journey, revealing why he has chosen not to use weight-loss medications and instead plans to pursue lifestyle changes on…

The Tennessee Poison Center is reporting a significant rise in calls related to exposure to tirzepatide and semaglutide—two FDA-approved medications widely used to treat Type 2 diabetes and support weight…

Novo Nordisk announced Tuesday that it will significantly reduce U.S. prices for its blockbuster medications Wegovy and Ozempic starting in 2027, underscoring mounting competition in the fast-growing market for weight-loss…

Owning a cat has long been linked to reduced stress and emotional support, but new research suggests our feline companions may also provide insights into treating certain cancers in humans.…

The first clinical patient has received a Clairity Breast cancer risk score, marking a historic milestone in women’s health and breast cancer prevention. Clairity Breast, developed by Boston-based Clairity Inc.,…

A new weight loss pill, Wegovy, is being hailed by doctors as a potential game changer in the fight against obesity, but experts caution that patients should approach it carefully.…

Researchers at Weill Cornell Medicine have discovered that ordinary fat cells in obese animals can be triggered to burn stored energy and produce substantial heat, according to a new preclinical…

Millions of Americans seeking popular weight-loss drugs such as Wegovy and Zepbound are turning to telehealth companies like Hims & Hers, which offer cheaper compounded alternatives. Originally, these compounded medications…

The U.S. Food and Drug Administration (FDA) has approved the Allurion Gastric Balloon, the first swallowable, non-surgical device for weight loss, the Massachusetts-based company announced Monday, Feb. 23. The approval…

The U.S. Food and Drug Administration (FDA) has accepted a supplemental biologics license application and granted priority review for Datroway (datopotamab deruxtecan), AstraZeneca announced. The therapy is intended for adult…

Researchers at QIMR Berghofer have uncovered a novel RNA molecule with the potential to transform the treatment of hormone receptor-positive (HR+) breast cancer, the most common form of the disease.…